Comments
Loading...

Cytokinetics

CYTKNASDAQ
Logo brought to you by Benzinga Data
$55.94
-0.22-0.39%
At Close: -
$55.94
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$106.00
Lowest Price Target1
$53.00
Consensus Price Target1
$75.10

Cytokinetics (NASDAQ:CYTK) Stock, Analyst Ratings, Price Targets, Forecasts

Cytokinetics Inc has a consensus price target of $75.1 based on the ratings of 22 analysts. The high is $106 issued by Oppenheimer on May 9, 2024. The low is $53 issued by Goldman Sachs on May 5, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co., JP Morgan, and JMP Securities on September 9, 2024, September 5, 2024, and September 4, 2024, respectively. With an average price target of $79.67 between HC Wainwright & Co., JP Morgan, and JMP Securities, there's an implied 42.41% upside for Cytokinetics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
3
2
May
1
Jun
1
Aug
2
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
JP Morgan
JMP Securities
Needham
Goldman Sachs

1calculated from analyst ratings

Analyst Ratings for Cytokinetics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Cytokinetics (CYTK) stock?

A

The latest price target for Cytokinetics (NASDAQ:CYTK) was reported by Cantor Fitzgerald on September 9, 2024. The analyst firm set a price target for $0.00 expecting CYTK to fall to within 12 months (a possible -100.00% downside). 51 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Cytokinetics (CYTK)?

A

The latest analyst rating for Cytokinetics (NASDAQ:CYTK) was provided by Cantor Fitzgerald, and Cytokinetics reiterated their overweight rating.

Q

When was the last upgrade for Cytokinetics (CYTK)?

A

There is no last upgrade for Cytokinetics

Q

When was the last downgrade for Cytokinetics (CYTK)?

A

The last downgrade for Cytokinetics Inc happened on August 13, 2024 when Goldman Sachs changed their price target from $85 to $60 for Cytokinetics Inc.

Q

When is the next analyst rating going to be posted or updated for Cytokinetics (CYTK)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cytokinetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cytokinetics was filed on September 9, 2024 so you should expect the next rating to be made available sometime around September 9, 2025.

Q

Is the Analyst Rating Cytokinetics (CYTK) correct?

A

While ratings are subjective and will change, the latest Cytokinetics (CYTK) rating was a reiterated with a price target of $0.00 to $0.00. The current price Cytokinetics (CYTK) is trading at is $55.94, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch